Dosage & Administration
Dosage & Administration Section (Direction)
Kaylaan Tablet, Chewable
FDA Label NDC 82091-112
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Kaylaan Llc for the product Kaylaan (NDC 82091-112). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage & administration, recent major changes, warnings, inactive ingredient, indications & usage, otc - keep out of reach of children, otc - purpose, otc - active ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Recent Major Changes
Dosage and Adminstration section falls under direction.
INDICATION AND USAGE updated
* Please review the disclaimer below.
